Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update

Go back to Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update
(NASDAQ: SYRS) Delayed: 0.12 --0 (-0%)
Previous Close $0.12    52 Week High $21.50 
Open $0.12    52 Week Low $8.16 
Day High $0.12    P/E N/A 
Day Low $0.12    EPS $0.00 
Volume 16,487